D04.11

Clinical Causes: Prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds. Fair skin, which is more susceptible to UV damage. A history of skin injuries or chronic skin inflammation in the eyelid area. Genetic predisposition to skin cancers. Immunosuppressive conditions or medications that weaken the immune system.

Key Symptoms: Appearance of a new growth or sore on the eyelid that doesn't heal. A small, scaly, or crusted patch on the skin of the eyelid or canthus. Redness or inflammation in the affected area. A persistent bump or thickening on the skin's surface. Possible slight bleeding or ulceration in the lesion area.

Diagnosis Path: Diagnosis typically involves a thorough examination of the eyelid and surrounding skin by a healthcare professional. A biopsy is key to confirming carcinoma in situ; this involves removing a small tissue sample from the abnormal area and analyzing it under a microscope. Additional imaging or dermatological assessments may be performed if necessary to rule out deeper tissue involvement or to plan appropriate treatment strategies.

Treatment Protocols: Management of carcinoma in situ of the eyelid aims to remove or eradicate abnormal cells while preserving the eye's function and appearance. Treatment options include: - Surgical excision, where the affected tissue is carefully removed. - Mohs micrographic surgery, a precise technique that removes cancerous cells layer by layer. - Topical treatments such as 5-fluorouracil or imiquimod cream, which can be applied directly to the lesion. - Cryotherapy, involving freezing of the abnormal tissue. - Radiotherapy in select cases. Follow-up care is essential to monitor for recurrence or potential progression to invasive cancer. Early treatment significantly improves the prognosis and reduces the risk of malignant transformation.